The Claim
Semaglutide is associated with significantly greater weight loss compared to liraglutide in both diabetic and non-diabetic populations, with a meta-regression coefficient of β = +1.67 (p < 0.001) favoring semaglutide after adjustment for other variables.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Semaglutide leads to more weight loss than liraglutide in people with or without diabetes, based on combined data from multiple studies. The difference is statistically significant, meaning it is unlikely to be due to chance.
See the scientific wording
Semaglutide is associated with significantly greater weight loss compared to liraglutide in both diabetic and non-diabetic populations, with a meta-regression coefficient of β = +1.67 (p < 0.001) favoring semaglutide after adjustment for other variables.
Semaglutide is a medicine that stays in the body longer and sticks tighter to its target, a special sensor for a natural hormone. This sensor tells the brain 'you are full' and slows down stomach emptying. Because semaglutide activates this sensor more strongly and for longer than liraglutide, it makes people feel fuller longer and absorb fewer calories, leading to greater weight loss.
What the research says
1 studyThe study found that people taking semaglutide lost more weight than those on liraglutide, confirming the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.